4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-002389
President & CEO sold 10,135 shares at $15.17 ($153,748)
- President & CEO acquired 90,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Warmuth Markus · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-02 | Grant or award : show line 1 in the form | +90,000 | 634,538 | D | ||
| 2026-01-05 | Sale : show line 2 in the form | −10,135 | $15.17 | $153,748 | 624,403 | D |
| Open-market sales · 10,135 sh · avg $15.17 · $153,748 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-02 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +406,000 | 406,000 | D |
Loading xslF345X05/ownership.xml…